Table 3.
Characterization of EBV latency profile in EBV-positive prostate carcinoma tissues.
| Sample ID | EBNA-LP | EBNA-1 | EBNA-2 | EBNA-3A | EBNA-3B | EBNA-3C | LMP-1 | LMP-2 | LMP-2A | LMP-2B | EBER-1 | EBER-2 | BHRF-1 | BZLF-1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prostate_RNA_7 | + | + | + | + | + | − | + | + | + | − | + | + | + | + |
| Prostate_RNA_12 | + | + | + | + | + | − | + | + | + | − | + | + | + | + |
| Prostate_RNA_14 | + | + | + | − | − | + | + | + | + | + | + | + | + | |
| Prostate_RNA_16 | − | + | + | − | + | − | + | + | + | + | + | − | − | − |
| Prostate_RNA_17 | + | + | + | + | − | − | + | + | + | − | + | + | + | + |
| Prostate_RNA_19 | − | + | + | − | − | − | − | + | − | + | + | − | − | − |
| Prostate_RNA_21 | + | + | + | + | + | − | + | − | + | + | + | − | + | − |
| Prostate_RNA_22 | − | + | + | − | − | − | − | − | + | + | + | − | − | + |
| Prostate_RNA_24 | + | + | + | − | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_27 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_28 | − | + | + | + | + | − | + | − | + | − | + | − | − | − |
| Prostate_RNA_34 | + | + | + | + | + | − | + | − | + | − | + | + | + | − |
| Prostate_RNA_38 | + | + | + | + | − | + | + | + | + | + | + | − | + | + |
| Prostate_RNA_40 | − | + | + | − | − | − | + | − | + | + | + | + | + | + |
| Prostate_RNA_41 | − | + | + | − | + | − | + | + | + | + | + | + | + | + |
| Prostate_RNA_42 | − | − | + | − | + | − | + | + | + | + | + | + | + | + |
| Prostate_RNA_43 | + | + | + | − | − | − | + | + | + | + | + | − | + | + |
| Prostate_RNA_51 | − | + | + | − | + | − | + | − | + | + | + | + | − | + |
| Prostate_RNA_52 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_53 | − | + | + | − | + | − | + | + | + | + | + | + | + | + |
| Prostate_RNA_54 | − | + | + | − | + | − | + | + | + | + | + | − | − | + |
| Prostate_RNA_59 | − | + | + | − | − | − | + | − | + | + | + | − | − | + |
| Prostate_RNA_63 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_64 | − | + | + | − | + | − | + | + | + | + | + | − | − | + |
| Prostate_RNA_ 65 | + | + | + | − | + | − | + | − | − | − | + | − | − | + |
| Prostate_RNA_66 | + | + | + | − | − | + | + | − | + | − | − | + | − | + |
| Prostate_RNA_69 | + | + | + | + | + | − | + | + | + | − | + | + | + | + |
| Prostate_RNA_72 | + | + | + | − | − | − | + | − | + | − | + | − | + | + |
| Prostate_RNA_77 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_79 | + | + | + | + | + | − | + | − | + | + | + | + | − | + |
| Prostate_RNA_82 | − | + | + | − | − | − | + | − | + | + | − | + | − | + |
| Prostate_RNA_86 | + | + | + | + | + | + | + | + | + | + | − | + | + | + |
| Prostate_RNA_89 | + | + | + | + | + | + | + | + | + | + | + | + | + | + |
| Prostate_RNA_90 | − | + | + | + | + | − | + | − | + | − | + | + | + | + |
| Prostate_RNA_99 | − | + | + | − | + | − | + | + | + | + | + | + | − | + |
| Prostate_RNA_100 | − | + | + | − | + | − | + | + | + | + | + | + | + | + |
| Prostate_RNA_102 | + | + | − | + | − | − | + | + | + | + | + | + | + | + |
| Prostate_RNA_106 | + | + | + | + | − | + | + | + | + | + | + | − | + | + |
| Prostate_RNA_109 | − | + | − | − | − | − | + | − | − | − | + | − | + | + |
The latency profile was mapped based on the expression of the following latency-associated genes: EBNA-3B, EBNA-3A, EBNA-2, EBNA-1, LMP-2A, LMP-2, LMP-1, EBNA-LP, EBNA-3C, EBNA-2B, EBER-2, EBER-1, BZLF-1, and BHRF-1. The + and − signs show the presence and absence of gene expression, respectively.